在當(dāng)今世界,一個(gè)增強(qiáng)的多學(xué)科專家之間的交流,促進(jìn)合作項(xiàng)目和科學(xué)家密切合作、工程師、行業(yè)的人來說,監(jiān)管機(jī)構(gòu)和醫(yī)生是絕對(duì)要求任何嘗試的成功開發(fā)和臨床應(yīng)用一個(gè)新的生物療法或一個(gè)創(chuàng)新的設(shè)備涉及集體使用生物材料、細(xì)胞和/或生物活性分子。“生物工程和生物技術(shù)前沿”渴望成為所有參與這一過程的人的論壇,彌合基礎(chǔ)科學(xué)發(fā)現(xiàn)和臨床應(yīng)用之間經(jīng)常存在的差距。
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
SCI熱門推薦期刊 >
SCI常見問題 >
職稱論文常見問題 >
EI常見問題 >